SCHEMBL3852663

SCHEMBL3852663

CNC(=O)c1nc(-c2noc(-c3ccncc3)n2)cnc1[AsH2]

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
RAB9A P51151 11/20 0.46
NPC1 O15118 10/20 0.46
SMN1; SMN2 Q16637 5/20 0.46
TP53 P04637 4/20 0.46
ALDH1A1 P00352 3/20 0.46
PKM P14618 2/20 0.46
MEN1 O00255 1/20 0.42
KMT2A Q03164 1/20 0.42
MAPT P10636 4/20 0.40
LMNA P02545 2/20 0.40
HPGD P15428 2/20 0.40
TSHR P16473 1/20 0.40
HTT P42858 1/20 0.40
NPSR1 Q6W5P4 1/20 0.40
HSD17B10 Q99714 2/20 0.39
NFKB1 P19838 1/20 0.39
NFKB2 Q00653 1/20 0.39
RELA Q04206 1/20 0.39
S1PR1 P21453 3/20 0.39
S1PR3 Q99500 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3462777 0.87 ATR (0.51) RAB9ANPC1SMN1; SMN2TP53ALDH1A1
SCHEMBL3873902 0.79 HDAC4 (0.41)
SCHEMBL3459736 0.77 ATR (0.56)
SCHEMBL3461838 0.76 ATR (0.55) RAB9ANPC1SMN1; SMN2TP53PKM
SCHEMBL3462574 0.70 ATR (0.68)
SCHEMBL3460735 0.68 PIK3CD (0.64)
SCHEMBL3837215 0.68 ATR (0.41) RAB9ANPC1LMNA
SCHEMBL3461606 0.68 ATR (0.55) RAB9ANPC1SMN1; SMN2TP53ALDH1A1
SCHEMBL3460789 0.67 PLK1 (0.50) PLK1
SCHEMBL3834567 0.65 PIK3CD (0.53) RAB9ANPC1SMN1; SMN2TP53MEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1501514-A4 PROTEIN KINASE MODULATORS AND METHODS OF USE EXELIXIS INC (US) 2009-08-26 EP disclosed
EP-1501514-A2 PROTEIN KINASE MODULATORS AND METHODS OF USE Exelixis, Inc. (US) 2005-02-02 EP disclosed
WO-2003093297-A2 PROTEIN KINASE MODULATORS AND METHODS OF USE EXELIXIS, INC. (US) 2003-11-13 WO disclosed